View in EDS HTML Full Text PDF Full Text

Cell cycle regulator MYBL2 is a distinct vulnerability in acute myeloid leukemia.

Saved in:
Bibliographic Details
Title: Cell cycle regulator MYBL2 is a distinct vulnerability in acute myeloid leukemia.
Authors: Küchler S; Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; Department of Pediatric Hematology and Oncology, University Hospital Dresden and National Center for Tumor Diseases (NCT/UCC) Dresden, Dresden, Germany.; Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany., Brilloff S; Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; Department of Pediatric Hematology and Oncology, University Hospital Dresden and National Center for Tumor Diseases (NCT/UCC) Dresden, Dresden, Germany.; Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany., Schäfer S; Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; Department of Pediatric Hematology and Oncology, University Hospital Dresden and National Center for Tumor Diseases (NCT/UCC) Dresden, Dresden, Germany.; Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany., Rahimian E; Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; Department of Pediatric Hematology and Oncology, University Hospital Dresden and National Center for Tumor Diseases (NCT/UCC) Dresden, Dresden, Germany.; Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany., Kufrin V; Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; Department of Pediatric Hematology and Oncology, University Hospital Dresden and National Center for Tumor Diseases (NCT/UCC) Dresden, Dresden, Germany.; Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany., Peri SS; Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany., Musa J; Department of General, Visceral, Thoracic, and Transplant Surgery, University Hospital of Giessen and Marburg, Giessen, Germany.; Division of Translational Pediatric Sarcoma Research, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany., Grünewald TGP; Division of Translational Pediatric Sarcoma Research, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany., Schewe DM; Department of Pediatric Hematology and Oncology, University Hospital Dresden and National Center for Tumor Diseases (NCT/UCC) Dresden, Dresden, Germany., Ball CR; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; German Cancer Consortium (DKTK), partner site Dresden, Dresden, Germany.; TU Dresden University of Technology, Faculty of Biology, Dresden, Germany., Bornhäuser M; Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; German Cancer Consortium (DKTK), partner site Dresden, Dresden, Germany., Glimm H; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; German Cancer Consortium (DKTK), partner site Dresden, Dresden, Germany.; Translational Functional Cancer Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Bill M; Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; German Cancer Consortium (DKTK), partner site Dresden, Dresden, Germany., Wurm AA; Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany. alexander.wurm@nct-dresden.de.; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany. alexander.wurm@nct-dresden.de.; Department of Pediatric Hematology and Oncology, University Hospital Dresden and National Center for Tumor Diseases (NCT/UCC) Dresden, Dresden, Germany. alexander.wurm@nct-dresden.de.; Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany. alexander.wurm@nct-dresden.de.; German Cancer Consortium (DKTK), partner site Dresden, Dresden, Germany. alexander.wurm@nct-dresden.de.
Source: Cell death discovery [Cell Death Discov] 2025 Oct 20; Vol. 11 (1), pp. 470. Date of Electronic Publication: 2025 Oct 20.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 101665035 Publication Model: Electronic Cited Medium: Print ISSN: 2058-7716 (Print) Linking ISSN: 20587716 NLM ISO Abbreviation: Cell Death Discov Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41115880
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cell cycle regulator MYBL2 is a distinct vulnerability in acute myeloid leukemia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Küchler+S%22">Küchler S</searchLink>; Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; Department of Pediatric Hematology and Oncology, University Hospital Dresden and National Center for Tumor Diseases (NCT/UCC) Dresden, Dresden, Germany.; Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Brilloff+S%22">Brilloff S</searchLink>; Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; Department of Pediatric Hematology and Oncology, University Hospital Dresden and National Center for Tumor Diseases (NCT/UCC) Dresden, Dresden, Germany.; Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Schäfer+S%22">Schäfer S</searchLink>; Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; Department of Pediatric Hematology and Oncology, University Hospital Dresden and National Center for Tumor Diseases (NCT/UCC) Dresden, Dresden, Germany.; Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Rahimian+E%22">Rahimian E</searchLink>; Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; Department of Pediatric Hematology and Oncology, University Hospital Dresden and National Center for Tumor Diseases (NCT/UCC) Dresden, Dresden, Germany.; Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Kufrin+V%22">Kufrin V</searchLink>; Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; Department of Pediatric Hematology and Oncology, University Hospital Dresden and National Center for Tumor Diseases (NCT/UCC) Dresden, Dresden, Germany.; Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Peri+SS%22">Peri SS</searchLink>; Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Musa+J%22">Musa J</searchLink>; Department of General, Visceral, Thoracic, and Transplant Surgery, University Hospital of Giessen and Marburg, Giessen, Germany.; Division of Translational Pediatric Sarcoma Research, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Grünewald+TGP%22">Grünewald TGP</searchLink>; Division of Translational Pediatric Sarcoma Research, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Schewe+DM%22">Schewe DM</searchLink>; Department of Pediatric Hematology and Oncology, University Hospital Dresden and National Center for Tumor Diseases (NCT/UCC) Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Ball+CR%22">Ball CR</searchLink>; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; German Cancer Consortium (DKTK), partner site Dresden, Dresden, Germany.; TU Dresden University of Technology, Faculty of Biology, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Bornhäuser+M%22">Bornhäuser M</searchLink>; Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; German Cancer Consortium (DKTK), partner site Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Glimm+H%22">Glimm H</searchLink>; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; German Cancer Consortium (DKTK), partner site Dresden, Dresden, Germany.; Translational Functional Cancer Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Bill+M%22">Bill M</searchLink>; Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; German Cancer Consortium (DKTK), partner site Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Wurm+AA%22">Wurm AA</searchLink>; Mildred Scheel Early Career Center, National Center for Tumor Diseases (NCT/UCC) Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany. alexander.wurm@nct-dresden.de.; Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany. alexander.wurm@nct-dresden.de.; Department of Pediatric Hematology and Oncology, University Hospital Dresden and National Center for Tumor Diseases (NCT/UCC) Dresden, Dresden, Germany. alexander.wurm@nct-dresden.de.; Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany. alexander.wurm@nct-dresden.de.; German Cancer Consortium (DKTK), partner site Dresden, Dresden, Germany. alexander.wurm@nct-dresden.de.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101665035%22">Cell death discovery</searchLink> [Cell Death Discov] 2025 Oct 20; Vol. 11 (1), pp. 470. <i>Date of Electronic Publication: </i>2025 Oct 20.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101665035 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2058-7716 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220587716%22">20587716 </searchLink><i>NLM ISO Abbreviation: </i>Cell Death Discov <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41115880
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41420-025-02810-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 470
    Titles:
      – TitleFull: Cell cycle regulator MYBL2 is a distinct vulnerability in acute myeloid leukemia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Küchler S
      – PersonEntity:
          Name:
            NameFull: Brilloff S
      – PersonEntity:
          Name:
            NameFull: Schäfer S
      – PersonEntity:
          Name:
            NameFull: Rahimian E
      – PersonEntity:
          Name:
            NameFull: Kufrin V
      – PersonEntity:
          Name:
            NameFull: Peri SS
      – PersonEntity:
          Name:
            NameFull: Musa J
      – PersonEntity:
          Name:
            NameFull: Grünewald TGP
      – PersonEntity:
          Name:
            NameFull: Schewe DM
      – PersonEntity:
          Name:
            NameFull: Ball CR
      – PersonEntity:
          Name:
            NameFull: Bornhäuser M
      – PersonEntity:
          Name:
            NameFull: Glimm H
      – PersonEntity:
          Name:
            NameFull: Bill M
      – PersonEntity:
          Name:
            NameFull: Wurm AA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 20
              M: 10
              Text: 2025 Oct 20
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2058-7716
          Numbering:
            – Type: volume
              Value: 11
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Cell death discovery
              Type: main
ResultId 1